US residentsThis site is intended for healthcare professionals outside the US.

References: 1. Signifor Summary of Product Characteristics. Novartis Pharma AG. 2. Colao A, Petersenn S, Newell-Price J, et al. A 12-month phase 3 study of pasireotide in Cushing's disease. N Engl J Med. 2012;366(10):914-924.